Hadfield, M. J., Mistry, H., Pelcovits, A., Bansal, R., Andrea, S., Chergui, A., … Khurshid, H. (2023). Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors. Am J Clin Oncol, 46(4), 183–184. https://doi.org/10.1097/COC.0000000000000984

Hadfield, Matthew J., Hetal Mistry, Ari Pelcovits, Rani Bansal, Sarah Andrea, Adel Chergui, Kristy Ramphal, Matthew Austin, and Humera Khurshid. “Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors.” Am J Clin Oncol 46, no. 4 (April 1, 2023): 183–84. https://doi.org/10.1097/COC.0000000000000984.

Hadfield MJ, Mistry H, Pelcovits A, Bansal R, Andrea S, Chergui A, et al. Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors. Am J Clin Oncol. 2023 Apr 1;46(4):183–4.

Hadfield, Matthew J., et al. “Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors.” Am J Clin Oncol, vol. 46, no. 4, Apr. 2023, pp. 183–84. Pubmed, doi:10.1097/COC.0000000000000984.

Hadfield MJ, Mistry H, Pelcovits A, Bansal R, Andrea S, Chergui A, Ramphal K, Austin M, Khurshid H. Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors. Am J Clin Oncol. 2023 Apr 1;46(4):183–184.